Search...
Compugen reports third quarter revenue of $1.9 million and cash position of $86.1 million
I'm PortAI, I can summarize articles.
Compugen Ltd. reported third quarter revenues of $1.9 million for Q3 2025, down from $17.1 million in Q3 2024. The company incurred a net loss of $7.0 million, compared to a profit of $1.3 million in the previous year. Research and development expenses decreased to $5.8 million, while general and administrative expenses fell to $2.2 million. Compugen's cash position stands at $86.1 million, with no debt, expected to fund operations until Q3 2027. The company also raised $1.6 million by selling shares in October 2025 and continues to advance its immuno-oncology pipeline.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments